Gut Pathogens (Jul 2022)

Rapid screening for antigenic characterization of GII.17 norovirus strains with variations in capsid gene

  • Yingyin Liao,
  • Liang Xue,
  • Junshan Gao,
  • Yueting Zuo,
  • Yanhui Liang,
  • Yueting Jiang,
  • Weicheng Cai,
  • Jiale Yang,
  • Jumei Zhang,
  • Yu Ding,
  • Moutong Chen,
  • Aiwu Wu,
  • Xiaoxia Kou,
  • Qingping Wu

DOI
https://doi.org/10.1186/s13099-022-00504-1
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 11

Abstract

Read online

Abstract The emergence of the novel GII.17 Kawasaki 2014 norovirus variant raising the interest of the public, has replaced GII.4 as the predominant cause of noroviruses outbreaks in East Asia during 2014–2015. Antigenic variation of the capsid protein is considered as one of the key mechanisms of norovirus evolution. In this study, we screened a panel of GII.17 mutants. First, we produced norovirus P proteins using cell-free protein synthesis (CFPS) system, comparing the results to pure proteins expressed in a cell-based system. Next, we determined the binding capability of specific monoclonal antibody (mAb) 2D11 using a unique set of wild-type GII.17 strains. Results of the EIA involving a panel of mutant cell-free proteins indicated that Q298 was the key residue within loop 1. These data highlighted the essential residues in the linear antibody binding characteristics of novel GII.17. Furthermore, it supported the CFPS as a promising tool for rapidly screening mutants via the scalable expression of norovirus P proteins.

Keywords